Login to Your Account

ADA Wrap

GLP-1 Receptor Agonists Crowd into Diabetes Market

By Peter Winter

Monday, June 18, 2012

As the 72nd annual scientific sessions of the American Diabetes Association (ADA) drew to a close last week, the world's leading diabetes experts were left in no doubt that the market for glucagon-like peptide-1 (GLP-1) receptor agonists is becoming highly competitive. 

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription